On May 23, Received Letter From Nasdaq Notifying Co's Adss Failed To Maintain Minimum Bid Price Required By Listing Rules
25/05/2022 22:28
May 25 (Reuters) - Mereo Biopharma Group PLC MAH0y.F :
* MEREO BIOPHARMA GROUP PLC - ON MAY 23, RECEIVED LETTER
FROM
NASDAQ NOTIFYING CO'S ADSS FAILED TO MAINTAIN MINIMUM BID PRICE
REQUIRED BY LISTING RULES
Further company coverage: MAH0y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mereo BioPharma
See all newsBrief: Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement For Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
UK's Mereo BioPharma Q2 loss narrows on lower R&D spending
Brief: Mereo BioPharma Q2 Operating Income USD -7.03 Million
Brief: Mereo BioPharma Q1 Net Income USD -6.719 Million
Brief: Mereo BioPharma FY Revenue USD 500 Thousand Vs. IBES Estimate USD 520 Thousand